Hypoxia Therapeutic Pipeline Review H2 2014 Report at ReportsnReports.com
Dallas,Texas (PRWEB) January 06, 2015 -- The report "Hypoxia - Pipeline Review, H2 2014" provides comprehensive information on the therapeutic development for Hypoxia. Hypoxia is a medical disorder which results when the body does not receive adequate oxygen supply. Hypoxia occurs in different parts of the body. The primary disorders are change in the heart rate, change in the color of skin, shortness of breath, etc. The repercussions can be fatal if a vital part of the body (like Brain) gets infected. Hypoxia may occur at the high altitudes of geography (high altitude pulmonary edema HAPE and high altitude cerebral edema HACE) and also at the places which has a low supply of breathable oxygen. The Symptoms when found need to be treated immediately through an external oxygen supply. The external oxygen supply can be in the form of Inhaler or asthma medicine given through mouth. The oxygen could also be provided through a vein in the arm (IV). Complete Report is Available @ http://www.reportsnreports.com/reports/322801-hypoxia-pipeline-review-h2-2014.html
It also reviews key players involved in the therapeutic development for Hypoxia and special features on late-stage and discontinued projects. Companies discussed in this Hypoxia Pipeline Review H2 2014 report include Baxter International Inc.
Drugs profile discussed in this Hypoxia Pipeline Review H2 2014 report include Aes-103, F-15845, S100-A8, S100-A9, Recombinant Proteins for Ischemia Reperfusion Injury. Order a Purchase copy of this report @ http://www.reportsnreports.com/purchase.aspx?name=322801
Table of Contents
List of Tables
Number of Products under Development for Hypoxia, H2 2014 7
Number of Products under Development for Hypoxia - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Number of Products under Investigation by Universities/Institutes, H2 2014 10
Comparative Analysis by Clinical Stage Development, H2 2014 11
Comparative Analysis by Early Stage Development, H2 2014 12
Products under Development by Companies, H2 2014 13
Products under Investigation by Universities/Institutes, H2 2014 14
Hypoxia - Pipeline by Baxter International Inc., H2 2014 15
Assessment by Monotherapy Products, H2 2014 16
Number of Products by Stage and Target, H2 2014 18
Number of Products by Stage and Mechanism of Action, H2 2014 20
Number of Products by Stage and Route of Administration, H2 2014 21
Number of Products by Stage and Molecule Type, H2 2014 23
Hypoxia Therapeutics - Recent Pipeline Updates, H2 2014 30
Hypoxia - Dormant Projects, H2 2014 32
List of Figures
Number of Products under Development for Hypoxia, H2 2014 7
Number of Products under Development for Hypoxia - Comparative Analysis, H2 2014 8
Number of Products under Investigation by Universities/Institutes, H2 2014 10
Comparative Analysis by Early Stage Products, H2 2014 12
Assessment by Monotherapy Products, H2 2014 16
Number of Products by Top 10 Targets, H2 2014 17
Number of Products by Stage and Top 10 Targets, H2 2014 17
Number of Products by Top 10 Mechanism of Actions, H2 2014 19
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 19
Number of Products by Top 10 Molecule Types, H2 2014 22
Number of Products by Stage and Top 10 Molecule Types, H2 2014 22
Explore more reports on Pharmaceuticals industry at http://www.reportsnreports.com/market-research/pharmaceuticals/ .
About Us:
ReportsnReports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, ReportsnReports, http://www.reportsnreports.com/, +1 (888) 391-5441, [email protected]
Share this article